CF PHtech (02652) spent 382,300 Hong Kong dollars repurchasing 18,500 shares on April 24th.
Changfeng Pharmaceuticals (02652) announced on April 24, 2026, that the company spent 382,300 Hong Kong dollars to repurchase 18,500 shares.
CF PHARMTECH (02652) announced that on April 24, 2026, the company spent HKD 382,300 to repurchase 18,500 shares.
Related Articles
VPOWER GROUP (01608) released its annual performance, with a net loss attributable to shareholders of HK$201 million, a decrease of 13.57% year-on-year.
Maanshan Iron reported a net profit attributable to shareholders of 42.3665 million yuan in the first quarter.
MINGFA GROUP (00846) announces its annual performance, with a net loss of 1.227 billion yuan attributable to shareholders, a decrease of 31.48% year-on-year.
VPOWER GROUP (01608) released its annual performance, with a net loss attributable to shareholders of HK$201 million, a decrease of 13.57% year-on-year.
Maanshan Iron reported a net profit attributable to shareholders of 42.3665 million yuan in the first quarter.
MINGFA GROUP (00846) announces its annual performance, with a net loss of 1.227 billion yuan attributable to shareholders, a decrease of 31.48% year-on-year.
RECOMMEND
The Great Transformation Of The Hong Kong Automotive Market
23/04/2026
Another “Elephant” Dances As China Construction Bank Hits A Record High While The Sector Remains Below Book Value, With Several Names Offering Elevated Dividend Yields
23/04/2026
Major Oil Traders Warn One Billion Barrel Shortfall Is Locked In, Hormuz Closure Could Trigger Recession
23/04/2026
